SenesTech Reaches a Distribution Agreement with Bug Off Pest Control Center of New York City for ContraPest®

SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced a distribution agreement with Bug Off Pest Control Center (“Bug Off”) for ContraPest®. In addition to distribution, Bug Off will be marketing and selling ContraPest throughout its network, and providing ongoing training to pest management professionals (PMPs) in the Greater New York area.

Loretta P. Mayer, Chair, CEO and co-founder of SenesTech.

“Andy Linares and Bug Off are well known and well respected in the pest management world. He brings a focus on innovation, education and service to his PMP customers, and we look forward to working with him to more rapidly penetrate the New York City market,” said Dr. Loretta P. Mayer, Chair, CEO and co-founder of SenesTech.

“New York is the biggest market for rodent control in the U.S.; the toughest, and the most sophisticated. My PMP customers rely on Bug Off to bring them the most innovative and the most effective solutions to their pest management challenges. ContraPest is a very promising product, and I am looking forward to partnering with the SenesTech team to bring it to our market,” said Andy Linares, President of Bug Off Pest Control Center.

Bug Off will immediately be a stocking distributor.

About SenesTech

SenesTech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction.

ContraPest® is an innovative technology that targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down. Our delivery system is designed to minimize handler exposure, and ContraPest is dispensed inside tamper resistant bait stations, minimizing the risks to non-target species.

As a versatile tool, ContraPest can be used within Integrated Pest Management (IPM) programs to help reduce reproduction and magnify the success of IPM protocols or as a standalone, non-lethal solution for customers that are looking to reduce or eliminate the use of lethal methodologies.

ContraPest is a Restricted Use Pesticide, due to applicator expertise. Please read and comply with all label instructions. For more information visit the SenesTech website at www.senestech.com.

Safe Harbor Statement
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan” or “planned,” “will” or “should,” “expected,” “anticipates,” “draft,” “eventually” or “projected.” You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in our filings with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

CONTACT:

Investor:

Robert Blum, Joe Dorame, Joe Diaz, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com

Company:

Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

SOURCE SenesTech

 

Posted in AZBio News.